Published in J Infect Dis on September 01, 1988
Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health (1992) 2.54
Barrier contraceptives and sexually transmitted diseases in women: a comparison of female-dependent methods and condoms. Am J Public Health (1992) 2.16
Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: comparative sensitivity of primary human vaginal keratinocytes. Antimicrob Agents Chemother (2000) 1.92
Commentary: the quest for women's prophylactic methods--hopes vs science. Am J Public Health (1992) 1.71
The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health (1994) 1.50
In vitro preclinical testing of nonoxynol-9 as potential anti-human immunodeficiency virus microbicide: a retrospective analysis of results from five laboratories. Antimicrob Agents Chemother (2006) 1.37
The protective effect of condoms and nonoxynol-9 against HIV infection. Am J Public Health (1998) 1.28
In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother (1998) 1.26
HIV prevention: an update on the status of methods women can use. Am J Public Health (1993) 1.23
Randomized controlled trials of interventions to prevent sexually transmitted infections: learning from the past to plan for the future. Epidemiol Rev (2010) 1.02
Spermicide acceptability among patients at a sexually transmitted disease clinic in Zambia. Am J Public Health (1995) 0.87
Vaginal microbicides for reducing the risk of sexual acquisition of HIV infection in women: systematic review and meta-analysis. BMC Infect Dis (2012) 0.87
Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review. Genitourin Med (1994) 0.86
Pharmacokinetic study to compare the absorption and tolerability of two doses of levonorgestrel following single vaginal administration of levonorgestrel in Carraguard gel: a new formulation for "dual protection" contraception. Contraception (2007) 0.84
Contraceptive methods and the transmission of HIV: implications for family planning. Genitourin Med (1994) 0.78
A randomized controlled trial comparing nonoxynol-9 lubricated condoms with silicone lubricated condoms for prophylaxis. Sex Transm Infect (1998) 0.76
The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team. N Engl J Med (1992) 9.10
The changing epidemiology of hepatitis B in the United States. Need for alternative vaccination strategies. JAMA (1990) 6.09
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med (1992) 5.11
Pneumocystis carinii infection: evidence for high prevalence in normal and immunosuppressed children. Pediatrics (1978) 4.44
Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med (1982) 3.66
Comparative study of diagnostic procedures for congenital cytomegalovirus infection. Pediatrics (1980) 3.53
Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. JAMA (1990) 3.41
Importance of heterosexual activity in the transmission of hepatitis B and non-A, non-B hepatitis. JAMA (1989) 3.39
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA (1986) 3.37
Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics (1980) 3.21
Transfusion-associated acquired immunodeficiency syndrome. Evidence for persistent infection in blood donors. N Engl J Med (1985) 2.62
Association of Ureaplasma urealyticum infection of the lower respiratory tract with chronic lung disease and death in very-low-birth-weight infants. Lancet (1988) 2.52
Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J (1992) 2.40
Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics (1980) 2.35
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Nephrotic syndrome: an under-recognised immune-mediated complication of non-myeloablative allogeneic haematopoietic cell transplantation. Br J Haematol (2005) 2.32
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med (1973) 2.21
Oral contraceptive use and the risk of chlamydial and gonococcal infections. Am J Obstet Gynecol (1989) 2.18
Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiol (1996) 2.17
Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency. N Engl J Med (1974) 2.16
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Congenital and perinatal cytomegalovirus infections. Rev Infect Dis (1990) 2.04
Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis (1975) 1.97
Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics (1999) 1.96
An efficient program for computing conditional maximum likelihood estimates and exact confidence limits for a common odds ratio. Epidemiology (1991) 1.91
Mechanical failure of the latex condom in a cohort of women at high STD risk. Sex Transm Dis (1999) 1.90
Effectiveness of an intervention promoting the female condom to patients at sexually transmitted disease clinics. Am J Public Health (2000) 1.80
Demographic and geographic variability of kidney stones in the United States. Kidney Int (1994) 1.75
Congenital toxoplasmosis: clinical, laboratory, and therapeutic considerations, with special reference to subclinical disease. Bull N Y Acad Med (1974) 1.69
Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics (1977) 1.66
Confounding by time since hire in internal comparisons of cumulative exposure in occupational cohort studies. Epidemiology (1993) 1.66
Isolation of Mycoplasma hominis and Ureaplasma urealyticum from amniotic fluid at 16-20 weeks of gestation: potential effect on outcome of pregnancy. Sex Transm Dis (1984) 1.64
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: a prospective study. Pediatrics (1981) 1.57
Prevalence of the prothrombin 20210 G-to-A variant in blacks: infants, patients with venous thrombosis, patients with myocardial infarction, and control subjects. J Lab Clin Med (1998) 1.53
Possibility of selection bias in matched case-control studies using friend controls. Am J Epidemiol (1986) 1.52
von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol (2001) 1.51
Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. Ann Intern Med (1983) 1.51
Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization. Am J Dis Child (1979) 1.51
Cervical cytomegalovirus excretion in pregnant and nonpregnant women: suppression in early gestation. J Infect Dis (1975) 1.49
Immunoglobulin M antibodies detected by enzyme-linked immunosorbent assay and radioimmunoassay in the diagnosis of cytomegalovirus infections in pregnant women and newborn infants. J Clin Microbiol (1985) 1.48
Interview with Sergio Stagno: Isolation precautions for patients with cytomegalovirus infection. Pediatr Infect Dis (1983) 1.48
Herpesvirus infections of pregnancy. Part I: Cytomegalovirus and Epstein-Barr virus infections. N Engl J Med (1985) 1.47
Rapid diagnosis of pneumonia due to cytomegalovirus with specific monoclonal antibodies. J Infect Dis (1983) 1.47
Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther (1993) 1.47
Maternal cytomegalovirus infection and perinatal transmission. Clin Obstet Gynecol (1982) 1.46
Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med (1980) 1.46
Congenital and perinatal cytomegalovirus infections. Semin Perinatol (1983) 1.45
Safety of salmeterol in the maintenance treatment of asthma. Ann Allergy Asthma Immunol (1995) 1.43
A pilot study of 2-chloro-2'-deoxyadenosine in the treatment of systemic lupus erythematosus-associated glomerulonephritis. Arthritis Rheum (1998) 1.43
Cytomegalovirus infection of breast milk and transmission in infancy. Pediatrics (1983) 1.42
Immune complexes in congenital and natal cytomegalovirus infections of man. J Clin Invest (1977) 1.42
Breast self-examination: an adjuvant to early cancer detection. Am J Public Health (1981) 1.40
A follow-up study of methods of contraception, sexual activity, and rates of trichomoniasis, candidiasis, and bacterial vaginosis. Am J Obstet Gynecol (1990) 1.39
Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics (1997) 1.33
Early clinical manifestations and intellectual outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr (1987) 1.30
In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis. Antimicrob Agents Chemother (1985) 1.30
Infection with cytomegalovirus during pregnancy: specific IgM antibodies as a marker of recent primary infection. J Infect Dis (1982) 1.30
Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis (1993) 1.29
Simple anthropometric indices associated with ischemic heart disease. J Clin Epidemiol (1996) 1.29
Exact estimates for a rate ratio. Epidemiology (1996) 1.28
A case-control study of spermicides and gonorrhea. JAMA (1984) 1.28
Excretion of cytomegalovirus in mothers: observations after delivery of congenitally infected and normal infants. J Infect Dis (1982) 1.27
The epidemiology of venous thromboembolism in Caucasians and African-Americans: the GATE Study. J Thromb Haemost (2003) 1.27
Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis (1977) 1.26
Use of isolated nuclei in the indirect fluorescent-antibody test for human cytomegalovirus infection: comparison with microneutralization, anticomplement, and conventional indirect fluorescent-antibody assays. J Clin Microbiol (1978) 1.25
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1997) 1.24
Intrauterine herpes simplex virus infections. J Pediatr (1987) 1.22
Postictal psychiatric events during prolonged video-electroencephalographic monitoring studies. Arch Neurol (1996) 1.21
Recombinant human Dnase I (rhDNase) in patients with lupus nephritis. Lupus (1999) 1.19
Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med (1987) 1.19
Environmental tobacco smoke and lung cancer mortality in the American Cancer Society's Cancer Prevention Study. II. Cancer Causes Control (1997) 1.19
Racial differences in tumor grade among women with endometrial cancer. Gynecol Oncol (1995) 1.19
Comparative prevalence of subclinical cytomegalovirus and herpes simplex virus infections in the genital and urinary tracts of low-income, urban women. J Infect Dis (1979) 1.18
Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis (1983) 1.18
Protracted pneumonitis in young infants associated with perinatally acquired cytomegaloviral infection. J Pediatr (1976) 1.17
Evaluation of a microtiter plate fluorescent-antibody assay for rapid detection of human cytomegalovirus infection. J Clin Microbiol (1992) 1.16
Diet and endometrial cancer: a case-control study. Am J Epidemiol (1993) 1.16
Cigarette smoking and leukemia. J Chronic Dis (1986) 1.15
Monoclonal antibodies for rapid diagnosis and typing of genital herpes infections during pregnancy. Am J Obstet Gynecol (1983) 1.14
An outbreak of toxoplasmosis linked to cats. Pediatrics (1980) 1.12
Microbiologic study of infertile women at the time of diagnostic laparoscopy. Association of Ureaplasma urealyticum with a defined subpopulation. N Engl J Med (1983) 1.11
Restriction endonuclease analysis of cytomegalovirus deoxyribonucleic acid as an epidemiologic tool. Pediatrics (1982) 1.10
Prevalence and importance of congenital cytomegalovirus infection in three different populations. J Pediatr (1982) 1.10
Rapid diagnosis of cytomegalovirus infection in infants by electron microscopy. N Engl J Med (1978) 1.09
A collaborative study of patient-initiated treatment of recurrent genital herpes with topical acyclovir or placebo. J Infect Dis (1984) 1.07
Herpesvirus infections of pregnancy. Part II: Herpes simplex virus and varicella-zoster virus infections. N Engl J Med (1985) 1.04
Serological Investigation of the possibility of congenital transmission of papovavirus JC. Infect Immun (1981) 1.04
Serological investigation of BK papovavirus infection in pregnant women and their offspring. Infect Immun (1980) 1.04
Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med (1983) 1.04
Progressive hearing impairment in children with congenital cytomegalovirus infection. J Speech Hear Disord (1979) 1.04
Infant pneumonitis associated with cytomegalovirus, Chlamydia, Pneumocystis, and Ureaplasma: follow-up. Pediatrics (1987) 1.02
Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics (1986) 1.02
A case-control study of hepatocellular carcinoma and the hepatitis B virus, cigarette smoking, and alcohol consumption. Cancer Res (1986) 1.02
Emetic food poisoning caused by Bacillus cereus. Arch Intern Med (1981) 1.01